{"gene":"DLX2","run_date":"2026-04-28T17:46:02","timeline":{"discoveries":[{"year":2006,"finding":"The noncoding RNA Evf-2 (transcribed from the Dlx-5/6 ultraconserved region) forms a stable in vivo complex with DLX2 protein and acts as a transcriptional coactivator, specifically increasing DLX2-mediated transcriptional activity at the Dlx-5/6 enhancer in a target- and homeodomain-specific manner.","method":"Co-immunoprecipitation of Evf-2 ncRNA and DLX2 protein in vivo; luciferase enhancer reporter assays; neural explant treatment with Sonic hedgehog","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP (RNA-protein complex) plus functional reporter assays, moderate evidence from single lab with multiple orthogonal methods","pmids":["16705037"],"is_preprint":false},{"year":1997,"finding":"Mice lacking both Dlx-1 and Dlx-2 show a time-dependent block in striatal differentiation: early-born neurons migrate to form a striosome-enriched region, but later-born neurons accumulate in the proliferative zone, establishing that Dlx-1/2 are required for development of the striatal subventricular zone and differentiation of late-born striatal matrix neurons.","method":"Targeted null mutations of Dlx-1 and Dlx-2 in mice; histological and marker analysis of striatal development","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — clean double-KO with defined cellular phenotype, highly cited foundational paper","pmids":["9247261"],"is_preprint":false},{"year":1995,"finding":"Dlx-2 null mutation in mice causes abnormal forebrain differentiation and respecification of cranial neural crest cell fate, resulting in abnormal morphogenesis of proximal first and second branchial arch skeletal derivatives, demonstrating Dlx-2 controls both branchial arch and forebrain development.","method":"Gene targeting to generate Dlx-2 null mice; skeletal and histological analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined craniofacial and forebrain phenotype, highly cited foundational paper","pmids":["7590232"],"is_preprint":false},{"year":1997,"finding":"Dlx-1 and Dlx-2 are required for proximodistal patterning of the branchial arches; Dlx-1/2 double mutants uniquely lack maxillary molars, demonstrating overlapping and distinct roles in craniofacial skeletal patterning.","method":"Targeted null mutations of Dlx-1, Dlx-2, and Dlx-1/2 double knockout mice; skeletal and soft tissue analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — clean KO/double-KO with defined skeletal phenotypes, highly cited","pmids":["9187081"],"is_preprint":false},{"year":1997,"finding":"Dlx-1 and Dlx-2 specify maxillary molar ectomesenchyme as odontogenic; loss of both genes causes the molar ectomesenchyme to lose odontogenic potential and switch fate to chondrogenic, as shown by heterologous recombination between mutant and wild-type epithelium/mesenchyme and marker analysis.","method":"Dlx-1/2 double-KO mice; heterologous tissue recombination; molecular marker analysis (Barx1, Sox9)","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — clean KO with epistasis via tissue recombination and molecular markers","pmids":["9428417"],"is_preprint":false},{"year":2007,"finding":"Dlx1 and Dlx2 repress oligodendrocyte precursor cell (OPC) formation in the ventral telencephalon by acting on a common progenitor to determine neuronal versus oligodendroglial cell fate; Dlx1/2 negatively regulate Olig2-dependent OPC formation, and progenitors from Dlx1/2 mutant telencephalon differentiate into myelinating oligodendrocytes rather than neurons when transplanted.","method":"Dlx1/2 conditional KO mice; progenitor transplantation into wild-type mice; fate mapping","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — clean KO plus transplantation rescue experiment, strong evidence","pmids":["17678855"],"is_preprint":false},{"year":2008,"finding":"Dlx2 directly activates Arx transcription through a GABAergic enhancer element containing Dlx-binding sites; Dlx overexpression induces ectopic Arx expression and its isolated enhancer, while loss of Dlx reduces Arx expression. Arx mediates Dlx-dependent promotion of interneuron migration but not GABAergic cell fate commitment.","method":"Enhancer isolation and functional characterization; Dlx gain-of-function in Arx mutant tissue; loss-of-function in Dlx mutant tissue; genetic epistasis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — direct enhancer functional assay with gain- and loss-of-function genetics in multiple mutant backgrounds","pmids":["18923043"],"is_preprint":false},{"year":2008,"finding":"Dlx2 is necessary and sufficient for neurogenesis of virtually all OB interneurons from the lateral subependymal zone in adults, and promotes specification of periglomerular neurons toward a dopaminergic fate; this PGN subtype specification requires interaction with Pax6, as Pax6 deletion blocks Dlx2-mediated PGN specification.","method":"Retroviral vectors for cell-autonomous Dlx2 gain- and loss-of-function in adult brain; Pax6 conditional deletion; immunofluorescence","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — cell-autonomous retroviral loss/gain-of-function with genetic epistasis (Pax6 deletion)","pmids":["18562615"],"is_preprint":false},{"year":2001,"finding":"PITX2 directly binds bicoid-like elements in the Dlx2 promoter and activates Dlx2 transcription ~45-fold; Msx2 competes with PITX2 for binding to the same bicoid element and represses Dlx2 promoter activity; coexpression of PITX2 and Msx2 results in transcriptional antagonism at the Dlx2 promoter.","method":"Luciferase reporter assays; EMSA; co-expression in CHO and LS-8 tooth epithelial cell lines","journal":"Gene expression","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro reporter + EMSA, single lab","pmids":["11763998"],"is_preprint":false},{"year":2001,"finding":"BMP-2 signaling to the Col2alpha1 chondrocyte-specific enhancer requires Dlx-2; rBMP-2 upregulates Dlx-2 expression in chondroblasts at an early differentiation stage, and blocking Dlx-2 with antisense oligonucleotides or dominant-negative Smad1 abolishes BMP-2-stimulated Col2alpha1 enhancer activity, placing Dlx-2 downstream of BMP-2/Smad signaling in chondroblasts.","method":"Antisense oligonucleotides against Dlx-2; dominant-negative Smad1 expression; luciferase Col2alpha1 enhancer reporter; rBMP-2 treatment of TMC23 chondroblasts","journal":"DNA and cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — functional reporter with loss-of-function and epistasis, single lab","pmids":["11445007"],"is_preprint":false},{"year":2006,"finding":"DLX2 activates the Msx2 promoter and binds its DNA as a monomer and dimer; Lef-1 physically interacts with DLX2 (confirmed by Co-IP and pull-down), and co-expression of DLX2 with Lef-1 isoforms synergistically activates the Msx2 promoter; Msx2 can auto-regulate its own promoter and repress DLX2 activation in a dose-specific manner; ChIP confirmed Msx2 as a downstream target of DLX2 and Lef-1.","method":"ChIP assay; Co-immunoprecipitation; protein pull-down; luciferase reporter assays; deletion analysis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP + reciprocal Co-IP + pull-down + reporter assays, multiple orthogonal methods in one study","pmids":["17068080"],"is_preprint":false},{"year":2011,"finding":"DLX2 acts as a direct transcriptional repressor of TGFβ receptor II (TGFβRII) gene expression, reducing canonical Smad-dependent TGFβ signaling and p21CIP1 expression while increasing c-Myc; DLX2 also directly induces betacellulin expression to promote cell survival via EGF receptor signaling, thereby counteracting TGFβ-induced cell-cycle arrest and apoptosis.","method":"Dlx2 overexpression and knockdown in mammary epithelial cells; Western blot for pathway components; reporter assays; in vivo tumor and metastasis assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — multiple molecular mechanisms characterized by functional assays, in vitro and in vivo, single lab with multiple orthogonal methods","pmids":["21897365"],"is_preprint":false},{"year":2016,"finding":"DLX2 expression reduces the TTI1/TTI2/TEL2 complex (required for ATM stabilization), leading to reduced ATM-p53 signaling and senescence bypass; DLX2 overexpression extends replicative lifespan through this mechanism.","method":"Gain-of-function senescence bypass screen; Western blot for TTI1/TTI2/TEL2 complex components; ATM-p53 pathway analysis","journal":"Genes & development","confidence":"Medium","confidence_rationale":"Tier 2 — functional screen with mechanistic follow-up, single lab","pmids":["26833729"],"is_preprint":false},{"year":2015,"finding":"Dlx-2 is induced by TGF-β and Wnt signaling and mediates TGF-β/Wnt-induced EMT and glycolytic switch through transcriptional activation of Snail; Dlx-2/Snail signaling also suppresses cytochrome c oxidase (COX) subunits including COXVIc, linking Dlx-2 to mitochondrial repression.","method":"shRNA knockdown; overexpression; RT-PCR; Western blot in cancer cell lines","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 3 — KD/OE with phenotype and pathway placement but no direct binding shown, single lab","pmids":["25651912"],"is_preprint":false},{"year":2016,"finding":"Dlx-2 induces glutaminase (GLS1) expression in a TGF-β/Wnt-dependent manner; GLS1-mediated glutamine metabolism is required for Dlx-2-, TGF-β-, and Wnt-induced EMT and glycolytic switch; Dlx-2 and GLS1 maintain Snail mRNA levels by suppressing p53-dependent Snail-targeting microRNAs.","method":"shRNA knockdown of GLS1 and Dlx-2; glutamine deprivation; pharmacological inhibitors; in vivo metastasis assays","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 3 — KD with multiple phenotypic readouts, pathway placement via inhibitors, single lab","pmids":["26771232"],"is_preprint":false},{"year":2019,"finding":"DLX2 directly binds Dlx2-response cis-acting elements in the Osteocalcin (OCN) and Alp promoters to transactivate their expression, enhancing osteogenic differentiation and bone formation without affecting Runx2, Dlx5, Msx2, or Osterix levels.","method":"Chromatin immunoprecipitation (ChIP); site-directed mutagenesis; luciferase reporter assays; DLX2 overexpression in BMSCs and MC3T3-E1 cells; in vivo implantation in nude mice","journal":"International journal of oral science","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP + mutagenesis + reporter assays + in vivo validation, multiple orthogonal methods","pmids":["30880332"],"is_preprint":false},{"year":2018,"finding":"DLX2 directly drives Gad1, Gad2, and Vgat expression in cortical interneurons (CINs), as conditional Dlx1/2 knockouts show reduced mIPSC amplitude, fewer GABAergic synapses on excitatory neurons, and hypoplastic dendrites; Dlx1/2 also regulate GRIN2B expression.","method":"Conditional KO of Dlx1, Dlx2, Dlx1&2; electrophysiology (mIPSC recordings); ChIP-seq/reporter assays for direct transcriptional targets; immunostaining","journal":"Cerebral cortex","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with direct electrophysiological and molecular phenotyping, multiple orthogonal methods","pmids":["29028947"],"is_preprint":false},{"year":2004,"finding":"Dlx1 and Dlx2 are required for terminal differentiation and survival of late-born retinal ganglion cells (RGCs); Dlx1/2 null retinas show reduced GCL with increased RGC apoptosis, thinning of the optic nerve, and ectopic Crx expression in GCL, while early-born RGCs and amacrine/horizontal cells are largely unaffected.","method":"Dlx1/2 double-KO mice; histological and TUNEL analysis; marker analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — clean double-KO with defined retinal phenotype and cell-type specificity","pmids":["15604100"],"is_preprint":false},{"year":2007,"finding":"DLX2 directly binds a specific region of the TrkB promoter in retinal neuroepithelium during embryogenesis; ectopic Dlx2 expression in retinal explants activates TrkB expression, and Dlx2 knockdown in primary retinal cultures reduces TrkB expression, establishing TrkB as a direct Dlx2 transcriptional target required for RGC survival.","method":"ChIP assay; luciferase reporter assays; in vitro gain/loss-of-function in retinal explants and primary cultures","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP plus functional reporter + gain/loss-of-function, multiple orthogonal methods","pmids":["18086710"],"is_preprint":false},{"year":2017,"finding":"DLX1 and DLX2 function as direct transcriptional activators of Brn3b expression in the developing retina; Dlx2 knockdown in primary embryonic retinal cultures reduces Brn3b expression, and Dlx2 gain-of-function in utero increases Brn3b expression; Dlx1/2/Brn3b triple-KO shows near-total RGC loss with increased amacrine cells.","method":"Triple-KO mice (Dlx1/Dlx2/Brn3b); in utero electroporation for gain-of-function; primary retinal culture knockdown; ChIP/reporter assays","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis via triple-KO plus gain/loss-of-function in vivo and in vitro","pmids":["28356311"],"is_preprint":false},{"year":2012,"finding":"The Rb/E2F pathway directly controls Dlx1 and Dlx2 expression: repressor E2Fs bind Dlx forebrain-specific enhancer I12b and Dlx1/Dlx2 proximal promoter regions, and Rb deficiency results in dramatic reduction of Dlx1 and Dlx2 expression, loss of interneuron subtypes, and severe migration defects.","method":"ChIP assay in vitro and in vivo; Rb-deficient mouse brain analysis; E2F reporter assays; interneuron subtype marker analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — ChIP in vitro and in vivo plus genetic KO with defined neurological phenotype","pmids":["22699903"],"is_preprint":false},{"year":2005,"finding":"Dlx2 overexpression in neural tube (via in ovo electroporation) inhibits neural crest cell migration and induces N-cadherin and NCAM upregulation in branchial arch mesenchyme, causing increased cell-cell adhesion and mesenchymal condensation, suggesting Dlx2 regulates ectomesenchymal cell adhesion.","method":"In ovo electroporation of chick embryos; immunostaining for N-cadherin and NCAM; cell aggregation assays","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — direct gain-of-function in vivo with molecular readout, single lab","pmids":["15848386"],"is_preprint":false},{"year":2002,"finding":"Dlx2-expressing subpallial cells migrate ventrodorsally from the ganglionic eminences and give rise to astrocytes and oligodendrocytes in the white matter and cerebral cortex, as demonstrated by short-term lineage tracing using a Dlx2/tauLacZ knock-in.","method":"Dlx2/tauLacZ knock-in lineage tracing; immunohistochemistry for glial markers (Zebrin II); histological analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — direct lineage tracing experiment with functional consequence (gliogenesis)","pmids":["12427838"],"is_preprint":false},{"year":2009,"finding":"DLX2 promotes the lineage transition from neural stem cells (NSCs) to transit-amplifying precursors (TAPs) in the postnatal SVZ, and also enhances the proliferative response of neuronal progenitors to EGF, demonstrating that DLX2 and EGFR signaling interact at multiple levels to coordinate SVZ progenitor proliferation.","method":"Forced DLX2 expression in SVZ-isolated NSCs; in vitro EGF response assays; in vivo modulation of DLX2","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 3 — gain-of-function in isolated NSCs with defined proliferative phenotype, single lab","pmids":["19683576"],"is_preprint":false},{"year":2008,"finding":"I12b and URE2, two ultra-conserved DNA elements near the Dlx1/2 locus, are direct transcriptional targets of DLX2 in vivo; their proper activity requires Dlx1 and Dlx2 expression, as shown by Cre-mediated fate mapping and transgenic reporter analysis.","method":"Transgenic Cre-reporter mice; fate mapping; analysis in Dlx1/2 mutant background","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo transgenic reporter plus loss-of-function genetic validation, single lab","pmids":["19026749"],"is_preprint":false},{"year":2021,"finding":"Misexpression of Dlx2 alone in postnatal mouse OPCs is sufficient to switch their fate to GABAergic neurons within 2 days by downregulating Olig2 and upregulating a network of inhibitory neuron transcripts; after two weeks, some OPC-derived neurons generate trains of action potentials and form clusters of GABAergic synaptic proteins.","method":"Dlx2 misexpression in postnatal OPCs; immunostaining; electrophysiology; transcriptomic analysis","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 — direct gain-of-function with electrophysiological validation and molecular characterization","pmids":["33574458"],"is_preprint":false},{"year":2000,"finding":"Epithelial expression of Dlx2 in the first branchial arch is regulated by BMP4 (planar signaling within distal oral epithelium), while mesenchymal expression is regulated by FGF8 (from overlying epithelium); FGF8 also inhibits epithelial Dlx2 expression through a signaling pathway requiring the mesenchyme, establishing that BMP4 and FGF8 maintain distinct epithelial and mesenchymal Dlx2 expression domains.","method":"Transgenic lacZ reporter constructs; bead implantation for BMP4/FGF8 signaling; in situ hybridization","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — transgenic reporters plus direct growth factor manipulation in tissue, multiple approaches","pmids":["10603340"],"is_preprint":false},{"year":2016,"finding":"Radiation-induced DLX2 expression is dependent on Smad2/3 signaling; knockdown of Smad2/3 abrogates radiation-induced DLX2 upregulation, and DLX2 in turn promotes radioresistance and EMT in cancer cell lines.","method":"siRNA knockdown of Smad2/3 and DLX2; Western blot; colony formation assay; EMT marker analysis in irradiated A549 and MDA-MB-231 cells","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 3 — epistasis via siRNA knockdown, single lab, single method type","pmids":["26799321"],"is_preprint":false},{"year":2017,"finding":"BMP signaling through the type I receptor ALK-2 (ACVR1) induces DLX2 expression in glioma-initiating cells; DLX2 promotes apoptosis and neural differentiation of GICs, and valproic acid induces BMP2/4, ACVR1 and DLX2 expression with concomitant Smad1/5 phosphorylation.","method":"Silencing of ALK-2 and DLX2 by siRNA; mouse orthotopic transplantation model; Western blot for Smad1/5 phosphorylation; VPA treatment","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 3 — siRNA knockdown with in vivo validation, single lab","pmids":["28459464"],"is_preprint":false},{"year":2020,"finding":"DLX2 directly binds to the WNT1 promoter (confirmed by ChIP assay) and activates Wnt/β-catenin signaling, which in turn promotes osteogenic differentiation of hBMSCs; pharmacological inhibition of β-catenin (FH535) abolishes the enhanced osteogenic capability induced by DLX2.","method":"ChIP assay; luciferase reporter; Western blot; ALP assay; Alizarin red staining; FH535 inhibitor","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus epistasis via inhibitor, single lab","pmids":["32165291"],"is_preprint":false},{"year":2018,"finding":"DLX2 overexpression in chondrocytes inhibits MMP13 expression by directly binding to two Dlx2-response elements in the MMP13 promoter, resulting in increased accumulation of type II collagen and aggrecan (markers of early chondrocyte differentiation).","method":"Luciferase reporter assay; ChIP assay; overexpression in TMC23 chondroblasts; RT-PCR; Western blot","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP + luciferase reporter with promoter element characterization, single lab with multiple methods","pmids":["29787757"],"is_preprint":false},{"year":2017,"finding":"Mutant Runx2 induces miR-185-5p expression, which directly targets and suppresses DLX2 (confirmed by dual-luciferase reporter assay with DLX2 3'-UTR); DLX2 suppression by miR-185-5p impairs amelogenesis and osteogenesis.","method":"miRNA microarray; dual-luciferase reporter assay; RT-PCR; Western blot; mutagenesis in LS8 and MC3T3-E1 cells","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — luciferase reporter with mutagenesis confirming direct miRNA-DLX2 interaction, single lab","pmids":["29242628"],"is_preprint":false},{"year":2023,"finding":"JMJD3 demethylase promotes DLX2 expression by removing H3K27me3 repressive marks at the DLX2 locus; JMJD3 depletion phenocopies DLX2 loss in vascular smooth muscle cells (reduced proliferation, promoted apoptosis, altered collagen/MMP expression), and DLX2 overexpression in JMJD3-depleted cells restores intracranial aneurysm progression.","method":"JMJD3 knockdown; DLX2 overexpression/knockdown in HA-VSMCs; H3K27me3 ChIP; in vivo aneurysm model","journal":"The Tohoku journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP for H3K27me3 modification plus epistasis rescue experiment, single lab","pmids":["37286519"],"is_preprint":false},{"year":1997,"finding":"Antisense oligonucleotide-mediated knockdown of Dlx-2 (but not Dlx-1) in primary cultures of embryonic basal ganglia decreases MAP2 expression, reduces dendrite outgrowth, and increases cell proliferation, demonstrating that the Dlx-2 gene product regulates neuronal exit from the mitotic cycle and the capability to grow MAP2-positive dendrites.","method":"Antisense oligonucleotides against Dlx-2 in primary basal ganglia cultures; MAP2 and neurofilament immunostaining; BrdU proliferation assay","journal":"Journal of molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 3 — antisense knockdown with specific cellular phenotype, single lab","pmids":["9188040"],"is_preprint":false},{"year":2026,"finding":"DLX2 functions as a pioneer transcription factor, forming a complex with LAP2α through a 38-amino-acid homeodomain motif, interacting with nucleosomes to promote chromatin remodeling and activate a pro-craniofacial ectomesenchymal gene network; disrupting DLX2-LAP2α interaction or silencing Dlx2 targets markedly diminishes ectomesenchymal differentiation from ESCs.","method":"Co-immunoprecipitation of DLX2-LAP2α complex; domain mutagenesis (38-aa homeodomain motif deletion); chromatin remodeling assays; ESC differentiation; CUT&Tag","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1 — reconstitution of DLX2-LAP2α complex with mutagenesis and chromatin functional validation","pmids":["41533791"],"is_preprint":false},{"year":2025,"finding":"DLX2 controls neural cell fate determination in the ventral telencephalon by directly repressing Notch signaling genes and glial fate-promoting transcription factors, thereby inhibiting early oligodendroglial differentiation during neurogenesis; single-cell spatial transcriptomics identified a secondary proliferative zone in the ventral SVZ regulated by DLX2-Notch axis.","method":"Single-cell whole-genome spatial transcriptomics; multi-omic approach; DLX2 gain/loss-of-function; Notch pathway gene expression analysis","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — multi-omic single-cell approach with direct pathway analysis, preprint not yet peer-reviewed","pmids":[],"is_preprint":true}],"current_model":"DLX2 is a homeodomain transcription factor that acts as a pioneer factor (forming a complex with LAP2α to remodel chromatin), directly activates or represses target gene promoters/enhancers (including Arx, TrkB, Brn3b, Gad1/2, Vgat, Osteocalcin, Alp, Wnt1, MMP13, and TGFβRII), cooperates with the lncRNA Evf-2 as a transcriptional coactivator, is regulated upstream by BMP/FGF/Smad/Rb-E2F pathways and H3K27me3 demethylation, and controls cell fate decisions between GABAergic neurons and oligodendrocytes in the forebrain, cranial neural crest-derived skeletal patterning in branchial arches, and osteogenic/chondrogenic differentiation, while in cancer contexts it bypasses senescence by destabilizing the ATM-stabilizing TTI1/TTI2/TEL2 complex and promotes EMT through Snail and glutamine metabolism."},"narrative":{"teleology":[{"year":1995,"claim":"Establishing that DLX2 is required for both forebrain differentiation and branchial arch skeletal patterning answered the foundational question of where and when this transcription factor acts during embryogenesis.","evidence":"Dlx-2 null mice showing abnormal forebrain and respecified cranial neural crest fate","pmids":["7590232"],"confidence":"High","gaps":["Downstream transcriptional targets unknown","Mechanism of cell fate respecification undefined","Redundancy with Dlx-1 not yet dissected"]},{"year":1997,"claim":"Systematic analysis of Dlx-1, Dlx-2, and double-knockout mice revealed that DLX1/2 have overlapping roles in striatal neurogenesis, branchial arch patterning, odontogenic specification, and cell cycle exit, clarifying the cooperative logic of the Dlx gene family.","evidence":"Dlx-1/2 single and double-KO mice with skeletal, striatal, and dental phenotypes; tissue recombination experiments; antisense knockdown in basal ganglia cultures","pmids":["9247261","9187081","9428417","9188040"],"confidence":"High","gaps":["Direct transcriptional targets of DLX2 not identified","Whether DLX2 acts as activator or repressor unknown","Signaling pathways upstream of DLX2 in these contexts undefined"]},{"year":2000,"claim":"Identification of BMP4 and FGF8 as upstream regulators maintaining distinct epithelial and mesenchymal DLX2 expression domains in the branchial arch placed DLX2 downstream of key morphogenetic signaling pathways.","evidence":"Transgenic lacZ reporters with BMP4/FGF8 bead implantation in mouse mandibular arch","pmids":["10603340"],"confidence":"High","gaps":["Whether BMP/FGF regulate DLX2 directly or indirectly unresolved","Cis-regulatory elements mediating this regulation not mapped"]},{"year":2001,"claim":"Placing DLX2 downstream of BMP-2/Smad signaling in chondroblasts and demonstrating PITX2/Msx2 competition at the DLX2 promoter defined the transcriptional regulatory logic controlling DLX2 expression in skeletal and dental contexts.","evidence":"Antisense and dominant-negative Smad1 blocking BMP-2-induced Col2α1 enhancer activity; EMSA and luciferase reporters for PITX2/Msx2 binding to DLX2 promoter","pmids":["11445007","11763998"],"confidence":"Medium","gaps":["In vivo validation of PITX2-DLX2 regulatory axis lacking","Whether DLX2 directly binds Col2α1 enhancer not shown"]},{"year":2004,"claim":"Demonstrating that Dlx1/2 are required for late-born retinal ganglion cell survival extended the known developmental roles of DLX2 beyond forebrain and craniofacial tissues to the retina.","evidence":"Dlx1/2 double-KO retinal analysis showing RGC apoptosis and optic nerve thinning","pmids":["15604100"],"confidence":"High","gaps":["Direct transcriptional targets of DLX2 in retina unknown","Whether DLX2 acts cell-autonomously in RGCs not established"]},{"year":2006,"claim":"Discovery that the lncRNA Evf-2 forms a complex with DLX2 to coactivate the Dlx-5/6 enhancer, and that DLX2 synergizes with Lef-1 to activate Msx2, revealed two distinct modes of DLX2 transcriptional co-regulation — one RNA-dependent and one protein-protein dependent.","evidence":"Co-IP of Evf-2/DLX2 complex and enhancer reporter assays; ChIP and reciprocal Co-IP of DLX2-Lef-1 with Msx2 promoter activation","pmids":["16705037","17068080"],"confidence":"High","gaps":["Structural basis of Evf-2/DLX2 interaction unknown","Whether Evf-2 coactivation applies to targets beyond Dlx-5/6 enhancer untested","Genome-wide DLX2-Lef-1 co-occupancy not mapped"]},{"year":2007,"claim":"Establishing that DLX1/2 control the neuron-versus-oligodendrocyte fate decision by repressing Olig2-dependent OPC formation, and identifying TrkB as a direct DLX2 transcriptional target in retina, revealed DLX2 as a binary fate switch and defined its first direct target genes.","evidence":"Dlx1/2 conditional KO with OPC transplantation into wild-type brain; ChIP and gain/loss-of-function for DLX2 at TrkB promoter in retina","pmids":["17678855","18086710"],"confidence":"High","gaps":["Whether DLX2 directly binds Olig2 regulatory elements unknown","Mechanism by which DLX2 represses oligodendroglial fate not molecularly defined"]},{"year":2008,"claim":"Identification of Arx as a direct DLX2 target mediating interneuron migration, and demonstration that DLX2 is necessary and sufficient for olfactory bulb interneuron neurogenesis with Pax6-dependent dopaminergic subtype specification, mapped the downstream transcriptional cascade controlling GABAergic interneuron diversification.","evidence":"Enhancer isolation and genetic epistasis for Arx; retroviral gain/loss-of-function for DLX2 in adult SVZ with Pax6 conditional deletion","pmids":["18923043","18562615"],"confidence":"High","gaps":["Whether DLX2 directly interacts with Pax6 protein unknown","Full set of DLX2-regulated enhancers in interneurons not cataloged"]},{"year":2011,"claim":"Demonstrating that DLX2 directly represses TGFβRII to block TGFβ-induced growth arrest and apoptosis while inducing betacellulin/EGFR signaling revealed a pro-oncogenic mechanism through which a developmental transcription factor subverts growth control.","evidence":"DLX2 overexpression/knockdown in mammary epithelial cells with in vivo tumor and metastasis assays","pmids":["21897365"],"confidence":"High","gaps":["Whether TGFβRII repression involves direct DLX2 binding to promoter (ChIP) not shown in this study","Relevance to human cancer in vivo not validated"]},{"year":2012,"claim":"Establishing that the Rb/E2F pathway directly controls DLX2 expression by binding the I12b forebrain enhancer and proximal promoter linked DLX2 to cell cycle regulation and explained how Rb deficiency leads to interneuron loss.","evidence":"ChIP for E2F binding in vitro and in vivo; Rb-deficient mouse brain with interneuron phenotyping","pmids":["22699903"],"confidence":"High","gaps":["Which specific E2F family members are activating versus repressing DLX2 unclear","Whether E2F-DLX2 axis operates outside the forebrain unknown"]},{"year":2015,"claim":"Linking DLX2 to TGFβ/Wnt-induced EMT via Snail activation and metabolic reprogramming (glycolytic switch, GLS1-dependent glutamine metabolism) expanded the oncogenic function of DLX2 beyond growth control to include metabolic and migratory programs.","evidence":"shRNA knockdown and overexpression in cancer cell lines; GLS1 epistasis with in vivo metastasis assays","pmids":["25651912","26771232"],"confidence":"Medium","gaps":["Direct binding of DLX2 to Snail or GLS1 promoters not demonstrated by ChIP","Whether metabolic reprogramming is relevant to normal DLX2 developmental functions unknown"]},{"year":2016,"claim":"Discovery that DLX2 bypasses senescence by destabilizing the TTI1/TTI2/TEL2 complex to suppress ATM-p53 signaling provided a specific molecular mechanism for DLX2's oncogenic role distinct from its TGFβRII repression.","evidence":"Gain-of-function senescence bypass screen; Western blot for TTI1/TTI2/TEL2 complex","pmids":["26833729"],"confidence":"Medium","gaps":["Whether DLX2 transcriptionally represses TTI1/TTI2/TEL2 components or acts post-transcriptionally unresolved","Not independently confirmed"]},{"year":2017,"claim":"Triple-KO genetic epistasis demonstrated that DLX1/2 directly activate Brn3b to specify retinal ganglion cells, and that miR-185-5p targets DLX2 for suppression in skeletal lineages, revealing both a downstream effector in the retina and a post-transcriptional regulatory mechanism.","evidence":"Dlx1/Dlx2/Brn3b triple-KO with near-total RGC loss; dual-luciferase reporter confirming miR-185-5p targeting of DLX2 3'-UTR","pmids":["28356311","29242628"],"confidence":"High","gaps":["Whether Brn3b is sufficient to rescue RGC loss in Dlx1/2 mutants untested","Full spectrum of miRNAs regulating DLX2 not surveyed"]},{"year":2018,"claim":"Conditional knockout studies in cortical interneurons established that DLX1/2 directly drive GABAergic synaptic gene expression (Gad1, Gad2, Vgat) and are required for normal inhibitory synaptic transmission, and ChIP identified DLX2 binding at the MMP13 promoter to repress chondrocyte hypertrophy, expanding the catalog of direct targets across tissues.","evidence":"Conditional Dlx1/2 KO with mIPSC recordings and ChIP-seq/reporters; ChIP and luciferase for MMP13 in chondroblasts","pmids":["29028947","29787757"],"confidence":"High","gaps":["Genome-wide DLX2 cistrome in interneurons not fully characterized","Whether MMP13 repression is relevant in vivo during skeletal development unknown"]},{"year":2019,"claim":"ChIP and mutagenesis demonstrated that DLX2 directly transactivates Osteocalcin and Alp promoters to enhance bone formation independently of Runx2 and Osterix, establishing a direct osteogenic transcriptional program.","evidence":"ChIP, site-directed mutagenesis, luciferase reporters in BMSCs/MC3T3-E1 cells; in vivo implantation","pmids":["30880332"],"confidence":"High","gaps":["Whether DLX2 cooperates with other osteogenic factors at these promoters untested","Physiological requirement for DLX2 in adult bone homeostasis unknown"]},{"year":2021,"claim":"Demonstrating that DLX2 alone is sufficient to reprogram postnatal OPCs into functional GABAergic neurons within days confirmed DLX2 as a dominant determinant of the neuron-oligodendrocyte binary fate switch and opened therapeutic reprogramming possibilities.","evidence":"DLX2 misexpression in postnatal OPCs with electrophysiology and transcriptomics","pmids":["33574458"],"confidence":"High","gaps":["Long-term stability and integration of reprogrammed neurons not established","Whether DLX2-reprogrammed neurons are functionally equivalent to endogenous interneurons unknown"]},{"year":2025,"claim":"Identification of DLX2 as a pioneer transcription factor that complexes with LAP2α via a 38-amino-acid homeodomain motif to remodel chromatin and activate ectomesenchymal gene networks fundamentally redefined the mechanism by which DLX2 accesses its target genes.","evidence":"Co-IP, domain mutagenesis, CUT&Tag chromatin profiling, ESC differentiation assays","pmids":["41533791"],"confidence":"High","gaps":["Whether LAP2α interaction is required for DLX2 pioneer activity in neural contexts untested","Structural basis of DLX2-nucleosome interaction unresolved","Whether all DLX2 targets require pioneer activity unknown"]},{"year":null,"claim":"A comprehensive genome-wide DLX2 cistrome across developmental contexts, the structural basis of DLX2 pioneer activity and LAP2α interaction, and the relevance of DLX2's oncogenic mechanisms (TTI1/TTI2/TEL2, metabolic reprogramming) to normal physiology remain to be established.","evidence":"","pmids":[],"confidence":"Low","gaps":["No genome-wide DLX2 binding map across multiple tissues and developmental stages","No crystal or cryo-EM structure of DLX2 bound to nucleosome or LAP2α","Whether DLX2 pioneer activity is relevant in the forebrain or retina not tested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[6,10,15,18,29,30,34]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,6,10,11,15,16,18,19,29,30,34]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,10,15,34]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[34]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,6,10,11,15,16,18,19,29,30,34]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,2,3,4,5,7,17,19,22,25]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[34]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,11,26,28,29]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[1,5,6,7,16,25]}],"complexes":["DLX2-LAP2α chromatin remodeling complex","DLX2-Evf-2 lncRNA coactivator complex"],"partners":["LAP2A","LEF1","PAX6","PITX2","MSX2","SMAD1"],"other_free_text":[]},"mechanistic_narrative":"DLX2 is a homeodomain transcription factor that functions as a master regulator of cell fate decisions in the developing forebrain, retina, branchial arch ectomesenchyme, and skeletal lineages. It acts as a pioneer factor by forming a complex with LAP2α through a 38-amino-acid homeodomain motif to remodel chromatin and activate pro-ectomesenchymal gene networks [PMID:41533791], and it directly binds and transactivates targets including Arx, TrkB, Brn3b, Gad1/2, Vgat, Osteocalcin, Alp, WNT1, and Msx2 while repressing TGFβRII and MMP13 [PMID:18923043, PMID:18086710, PMID:28356311, PMID:29028947, PMID:30880332, PMID:21897365, PMID:29787757]. In the forebrain, DLX2 is essential for GABAergic interneuron differentiation, migration, and synaptic function, and it determines the neuron-versus-oligodendrocyte fate choice by repressing Olig2-dependent oligodendrocyte precursor formation [PMID:9247261, PMID:17678855, PMID:33574458]. In cancer contexts, DLX2 bypasses cellular senescence by destabilizing the TTI1/TTI2/TEL2 complex to suppress ATM-p53 signaling and promotes epithelial-mesenchymal transition through Snail induction and glutamine metabolism reprogramming [PMID:26833729, PMID:25651912, PMID:26771232]."},"prefetch_data":{"uniprot":{"accession":"Q07687","full_name":"Homeobox protein DLX-2","aliases":[],"length_aa":328,"mass_kda":34.2,"function":"Acts as a transcriptional activator (By similarity). Activates transcription of CGA/alpha-GSU, via binding to the downstream activin regulatory element (DARE) in the gene promoter (By similarity). Plays a role in terminal differentiation of interneurons, such as amacrine and bipolar cells in the developing retina. Likely to play a regulatory role in the development of the ventral forebrain (By similarity). May play a role in craniofacial patterning and morphogenesis (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q07687/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DLX2","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DLX2","total_profiled":1310},"omim":[{"mim_id":"620809","title":"ACHAETE-SCUTE FAMILY bHLH TRANSCRIPTION FACTOR 5; ASCL5","url":"https://www.omim.org/entry/620809"},{"mim_id":"620675","title":"LEUKODYSTROPHY, HYPOMYELINATING, 27; HLD27","url":"https://www.omim.org/entry/620675"},{"mim_id":"617479","title":"SSU2 HOMOLOG; SSUH2","url":"https://www.omim.org/entry/617479"},{"mim_id":"616404","title":"POLYMERASE I, RNA, SUBUNIT A; POLR1A","url":"https://www.omim.org/entry/616404"},{"mim_id":"608874","title":"OROFACIAL CLEFT 5; OFC5","url":"https://www.omim.org/entry/608874"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nuclear speckles","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"brain","ntpm":2.9}],"url":"https://www.proteinatlas.org/search/DLX2"},"hgnc":{"alias_symbol":["TES-1"],"prev_symbol":[]},"alphafold":{"accession":"Q07687","domains":[{"cath_id":"1.10.10.60","chopping":"157-210","consensus_level":"high","plddt":97.8015,"start":157,"end":210}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q07687","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q07687-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q07687-F1-predicted_aligned_error_v6.png","plddt_mean":58.47},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DLX2","jax_strain_url":"https://www.jax.org/strain/search?query=DLX2"},"sequence":{"accession":"Q07687","fasta_url":"https://rest.uniprot.org/uniprotkb/Q07687.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q07687/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q07687"}},"corpus_meta":[{"pmid":"10906711","id":"PMC_10906711","title":"Pallial and subpallial derivatives in the embryonic chick and mouse telencephalon, traced by the expression of the genes Dlx-2, Emx-1, Nkx-2.1, Pax-6, and Tbr-1.","date":"2000","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/10906711","citation_count":759,"is_preprint":false},{"pmid":"16705037","id":"PMC_16705037","title":"The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator.","date":"2006","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/16705037","citation_count":573,"is_preprint":false},{"pmid":"7687285","id":"PMC_7687285","title":"Spatially restricted expression of Dlx-1, Dlx-2 (Tes-1), Gbx-2, and Wnt-3 in the embryonic day 12.5 mouse forebrain defines potential transverse and longitudinal segmental boundaries.","date":"1993","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/7687285","citation_count":523,"is_preprint":false},{"pmid":"9247261","id":"PMC_9247261","title":"Mutations of the homeobox genes Dlx-1 and Dlx-2 disrupt the striatal subventricular zone and differentiation of late born striatal neurons.","date":"1997","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/9247261","citation_count":443,"is_preprint":false},{"pmid":"9187081","id":"PMC_9187081","title":"Role of the Dlx homeobox genes in proximodistal patterning of the branchial arches: mutations of Dlx-1, Dlx-2, and Dlx-1 and -2 alter morphogenesis of proximal skeletal and soft tissue structures derived from the first and second arches.","date":"1997","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/9187081","citation_count":388,"is_preprint":false},{"pmid":"7590232","id":"PMC_7590232","title":"Null mutation of Dlx-2 results in abnormal morphogenesis of proximal first and second branchial arch derivatives and abnormal differentiation in the forebrain.","date":"1995","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7590232","citation_count":321,"is_preprint":false},{"pmid":"17678855","id":"PMC_17678855","title":"Dlx1 and Dlx2 control neuronal versus oligodendroglial cell fate acquisition in the developing forebrain.","date":"2007","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/17678855","citation_count":293,"is_preprint":false},{"pmid":"10516593","id":"PMC_10516593","title":"DLX-1, DLX-2, and DLX-5 expression define distinct stages of basal forebrain differentiation.","date":"1999","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/10516593","citation_count":238,"is_preprint":false},{"pmid":"7893603","id":"PMC_7893603","title":"Differential and overlapping expression domains of Dlx-2 and Dlx-3 suggest distinct roles for Distal-less homeobox genes in craniofacial development.","date":"1994","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/7893603","citation_count":217,"is_preprint":false},{"pmid":"9428417","id":"PMC_9428417","title":"Role of Dlx-1 and Dlx-2 genes in patterning of the murine dentition.","date":"1997","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9428417","citation_count":195,"is_preprint":false},{"pmid":"8098616","id":"PMC_8098616","title":"The mouse Dlx-2 (Tes-1) gene is expressed in spatially restricted domains of the forebrain, face and limbs in midgestation mouse embryos.","date":"1993","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/8098616","citation_count":194,"is_preprint":false},{"pmid":"7965042","id":"PMC_7965042","title":"DLX-2, MASH-1, and MAP-2 expression and bromodeoxyuridine incorporation define molecularly distinct cell populations in the embryonic mouse forebrain.","date":"1994","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/7965042","citation_count":185,"is_preprint":false},{"pmid":"18562615","id":"PMC_18562615","title":"A dlx2- and pax6-dependent transcriptional code for periglomerular neuron specification in the adult olfactory bulb.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18562615","citation_count":164,"is_preprint":false},{"pmid":"18923043","id":"PMC_18923043","title":"Arx is a direct target of Dlx2 and thereby contributes to the tangential migration of GABAergic interneurons.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18923043","citation_count":119,"is_preprint":false},{"pmid":"12427838","id":"PMC_12427838","title":"Subpallial dlx2-expressing cells give rise to astrocytes and oligodendrocytes in the cerebral cortex and white matter.","date":"2002","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12427838","citation_count":93,"is_preprint":false},{"pmid":"19026749","id":"PMC_19026749","title":"Generation of Cre-transgenic mice using Dlx1/Dlx2 enhancers and their characterization in GABAergic interneurons.","date":"2008","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/19026749","citation_count":89,"is_preprint":false},{"pmid":"17494687","id":"PMC_17494687","title":"Distinct cis-regulatory elements from the Dlx1/Dlx2 locus mark different progenitor cell populations in the ganglionic eminences and different subtypes of adult cortical interneurons.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17494687","citation_count":87,"is_preprint":false},{"pmid":"10603340","id":"PMC_10603340","title":"Independent regulation of Dlx2 expression in the epithelium and mesenchyme of the first branchial arch.","date":"2000","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10603340","citation_count":86,"is_preprint":false},{"pmid":"30880332","id":"PMC_30880332","title":"Overexpression of Dlx2 enhances osteogenic differentiation of BMSCs and MC3T3-E1 cells via direct upregulation of Osteocalcin and Alp.","date":"2019","source":"International journal of oral science","url":"https://pubmed.ncbi.nlm.nih.gov/30880332","citation_count":73,"is_preprint":false},{"pmid":"29028947","id":"PMC_29028947","title":"Dlx1 and Dlx2 Promote Interneuron GABA Synthesis, Synaptogenesis, and Dendritogenesis.","date":"2018","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/29028947","citation_count":71,"is_preprint":false},{"pmid":"8812481","id":"PMC_8812481","title":"Sequence, organization, and transcription of the Dlx-1 and Dlx-2 locus.","date":"1996","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8812481","citation_count":71,"is_preprint":false},{"pmid":"26771232","id":"PMC_26771232","title":"Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26771232","citation_count":68,"is_preprint":false},{"pmid":"15604100","id":"PMC_15604100","title":"Dlx1 and Dlx2 function is necessary for terminal differentiation and survival of late-born retinal ganglion cells in the developing mouse retina.","date":"2004","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15604100","citation_count":67,"is_preprint":false},{"pmid":"11763998","id":"PMC_11763998","title":"Antagonistic regulation of Dlx2 expression by PITX2 and Msx2: implications for tooth development.","date":"2001","source":"Gene expression","url":"https://pubmed.ncbi.nlm.nih.gov/11763998","citation_count":62,"is_preprint":false},{"pmid":"21897365","id":"PMC_21897365","title":"Transcription factor Dlx2 protects from TGFβ-induced cell-cycle arrest and apoptosis.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21897365","citation_count":55,"is_preprint":false},{"pmid":"11445007","id":"PMC_11445007","title":"Bone morphogenetic protein-2 (BMP-2) signaling to the Col2alpha1 gene in chondroblasts requires the homeobox gene Dlx-2.","date":"2001","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11445007","citation_count":43,"is_preprint":false},{"pmid":"11180958","id":"PMC_11180958","title":"A zebrafish forebrain-specific zinc finger gene can induce ectopic dlx2 and dlx6 expression.","date":"2001","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11180958","citation_count":43,"is_preprint":false},{"pmid":"7869122","id":"PMC_7869122","title":"Regionalization of the developing forebrain: a comparison of FORSE-1, Dlx-2, and BF-1.","date":"1995","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/7869122","citation_count":42,"is_preprint":false},{"pmid":"22699903","id":"PMC_22699903","title":"The Rb/E2F pathway modulates neurogenesis through direct regulation of the Dlx1/Dlx2 bigene cluster.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22699903","citation_count":41,"is_preprint":false},{"pmid":"15210202","id":"PMC_15210202","title":"Cloning and developmental expression patterns of Dlx2, Lhx7 and Lhx9 in the medaka fish (Oryzias latipes).","date":"2004","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/15210202","citation_count":41,"is_preprint":false},{"pmid":"29242628","id":"PMC_29242628","title":"Mutant Runx2 regulates amelogenesis and osteogenesis through a miR-185-5p-Dlx2 axis.","date":"2017","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29242628","citation_count":40,"is_preprint":false},{"pmid":"21108812","id":"PMC_21108812","title":"Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231.","date":"2010","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21108812","citation_count":40,"is_preprint":false},{"pmid":"12902388","id":"PMC_12902388","title":"Dlx2 progenitor migration in wild type and Nkx2.1 mutant telencephalon.","date":"2003","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/12902388","citation_count":39,"is_preprint":false},{"pmid":"19683576","id":"PMC_19683576","title":"Interaction between DLX2 and EGFR regulates proliferation and neurogenesis of SVZ precursors.","date":"2009","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/19683576","citation_count":38,"is_preprint":false},{"pmid":"27336609","id":"PMC_27336609","title":"KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer-a targeted molecular approach.","date":"2016","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27336609","citation_count":37,"is_preprint":false},{"pmid":"31920462","id":"PMC_31920462","title":"Long non-coding RNA TUG1 promotes cell progression in hepatocellular carcinoma via regulating miR-216b-5p/DLX2 axis.","date":"2020","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/31920462","citation_count":35,"is_preprint":false},{"pmid":"1354641","id":"PMC_1354641","title":"DLX2 (TES1), a homeobox gene of the Distal-less family, assigned to conserved regions on human and mouse chromosomes 2.","date":"1992","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1354641","citation_count":35,"is_preprint":false},{"pmid":"16964386","id":"PMC_16964386","title":"OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer.","date":"2006","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/16964386","citation_count":34,"is_preprint":false},{"pmid":"25651912","id":"PMC_25651912","title":"Dlx-2 is implicated in TGF-β- and Wnt-induced epithelial-mesenchymal, glycolytic switch, and mitochondrial repression by Snail activation.","date":"2015","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25651912","citation_count":34,"is_preprint":false},{"pmid":"28459464","id":"PMC_28459464","title":"Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells.","date":"2017","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/28459464","citation_count":33,"is_preprint":false},{"pmid":"32065989","id":"PMC_32065989","title":"ASCL1- and DLX2-induced GABAergic neurons from hiPSC-derived NPCs.","date":"2020","source":"Journal of neuroscience methods","url":"https://pubmed.ncbi.nlm.nih.gov/32065989","citation_count":33,"is_preprint":false},{"pmid":"22371698","id":"PMC_22371698","title":"Dynamic expression of the pro-dopaminergic transcription factors Pax6 and Dlx2 during postnatal olfactory bulb neurogenesis.","date":"2012","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22371698","citation_count":33,"is_preprint":false},{"pmid":"10750557","id":"PMC_10750557","title":"Biomineralization, life-time of odontogenic cells and differential expression of the two homeobox genes MSX-1 and DLX-2 in transgenic mice.","date":"2000","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/10750557","citation_count":32,"is_preprint":false},{"pmid":"28356311","id":"PMC_28356311","title":"Regulation of Brn3b by DLX1 and DLX2 is required for retinal ganglion cell differentiation in the vertebrate retina.","date":"2017","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28356311","citation_count":28,"is_preprint":false},{"pmid":"15848386","id":"PMC_15848386","title":"Dlx2 over-expression regulates cell adhesion and mesenchymal condensation in ectomesenchyme.","date":"2005","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15848386","citation_count":28,"is_preprint":false},{"pmid":"7554927","id":"PMC_7554927","title":"The spatial localization of Dlx-2 during tooth development.","date":"1995","source":"Connective tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/7554927","citation_count":28,"is_preprint":false},{"pmid":"26799321","id":"PMC_26799321","title":"Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26799321","citation_count":27,"is_preprint":false},{"pmid":"17068080","id":"PMC_17068080","title":"Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2.","date":"2006","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17068080","citation_count":26,"is_preprint":false},{"pmid":"23674878","id":"PMC_23674878","title":"Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.","date":"2013","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/23674878","citation_count":26,"is_preprint":false},{"pmid":"12722102","id":"PMC_12722102","title":"Dlx-1 and Dlx-2 expression in the adult mouse brain: relationship to dopaminergic phenotypic regulation.","date":"2003","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12722102","citation_count":26,"is_preprint":false},{"pmid":"20883215","id":"PMC_20883215","title":"Role of Dlx genes in craniofacial morphogenesis: Dlx2 influences skeletal patterning by inducing ectomesenchymal aggregation in ovo.","date":"2010","source":"Evolution & development","url":"https://pubmed.ncbi.nlm.nih.gov/20883215","citation_count":24,"is_preprint":false},{"pmid":"32977948","id":"PMC_32977948","title":"Knockdown of circ_HIPK3 inhibits tumorigenesis of hepatocellular carcinoma via the miR-582-3p/DLX2 axis.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/32977948","citation_count":23,"is_preprint":false},{"pmid":"21917150","id":"PMC_21917150","title":"Homeobox gene Dlx-2 is implicated in metabolic stress-induced necrosis.","date":"2011","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21917150","citation_count":23,"is_preprint":false},{"pmid":"23246068","id":"PMC_23246068","title":"The effect of overexpression of Dlx2 on the migration, proliferation and osteogenic differentiation of cranial neural crest stem cells.","date":"2012","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/23246068","citation_count":22,"is_preprint":false},{"pmid":"26833729","id":"PMC_26833729","title":"A gain-of-function senescence bypass screen identifies the homeobox transcription factor DLX2 as a regulator of ATM-p53 signaling.","date":"2016","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/26833729","citation_count":21,"is_preprint":false},{"pmid":"24294369","id":"PMC_24294369","title":"Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters.","date":"2013","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24294369","citation_count":21,"is_preprint":false},{"pmid":"32165291","id":"PMC_32165291","title":"DLX2 activates Wnt1 transcription and mediates Wnt/β-catenin signal to promote osteogenic differentiation of hBMSCs.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/32165291","citation_count":19,"is_preprint":false},{"pmid":"31891797","id":"PMC_31891797","title":"Actinidia Chinensis Planch Root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting the DLX2/TARBP2/JNK/AKT pathway.","date":"2019","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31891797","citation_count":19,"is_preprint":false},{"pmid":"17969168","id":"PMC_17969168","title":"GAD isoforms exhibit distinct spatiotemporal expression patterns in the developing mouse lens: correlation with Dlx2 and Dlx5.","date":"2007","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/17969168","citation_count":19,"is_preprint":false},{"pmid":"33574458","id":"PMC_33574458","title":"Direct reprogramming of oligodendrocyte precursor cells into GABAergic inhibitory neurons by a single homeodomain transcription factor Dlx2.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33574458","citation_count":19,"is_preprint":false},{"pmid":"18086710","id":"PMC_18086710","title":"Dlx2 homeobox gene transcriptional regulation of Trkb neurotrophin receptor expression during mouse retinal development.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/18086710","citation_count":19,"is_preprint":false},{"pmid":"30861584","id":"PMC_30861584","title":"Expression of ventral telencephalon transcription factors ASCL1 and DLX2 in the early fetal human cerebral cortex.","date":"2019","source":"Journal of anatomy","url":"https://pubmed.ncbi.nlm.nih.gov/30861584","citation_count":18,"is_preprint":false},{"pmid":"21357706","id":"PMC_21357706","title":"Up-regulation of homeodomain genes, DLX1 and DLX2, by FLT3 signaling.","date":"2011","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/21357706","citation_count":18,"is_preprint":false},{"pmid":"15376329","id":"PMC_15376329","title":"Identification and characterization of a novel transcript down-regulated in Dlx1/Dlx2 and up-regulated in Pax6 mutant telencephalon.","date":"2004","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15376329","citation_count":18,"is_preprint":false},{"pmid":"16301813","id":"PMC_16301813","title":"Identification of an HLA-A24-restricted OY-TES-1 epitope recognized by cytotoxic T-cells.","date":"2005","source":"Microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16301813","citation_count":17,"is_preprint":false},{"pmid":"9188040","id":"PMC_9188040","title":"Dlx-2 homeobox gene controls neuronal differentiation in primary cultures of developing basal ganglia.","date":"1997","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/9188040","citation_count":16,"is_preprint":false},{"pmid":"7901126","id":"PMC_7901126","title":"The human brain homeogene, DLX-2: cDNA sequence and alignment with the murine homologue.","date":"1993","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/7901126","citation_count":16,"is_preprint":false},{"pmid":"22651134","id":"PMC_22651134","title":"Knockdown of OY-TES-1 by RNAi causes cell cycle arrest and migration decrease in bone marrow-derived mesenchymal stem cells.","date":"2012","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/22651134","citation_count":16,"is_preprint":false},{"pmid":"26339343","id":"PMC_26339343","title":"Down-regulation of cancer/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro.","date":"2015","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26339343","citation_count":15,"is_preprint":false},{"pmid":"28529561","id":"PMC_28529561","title":"Serum immunoreactivity of cancer/testis antigen OY-TES-1 and its tissues expression in glioma.","date":"2017","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/28529561","citation_count":14,"is_preprint":false},{"pmid":"29787757","id":"PMC_29787757","title":"Dlx2 overexpression enhanced accumulation of type II collagen and aggrecan by inhibiting MMP13 expression in mice chondrocytes.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29787757","citation_count":13,"is_preprint":false},{"pmid":"35644412","id":"PMC_35644412","title":"LncRNA HOTTIP facilitates osteogenic differentiation in bone marrow mesenchymal stem cells and induces angiogenesis via interacting with TAF15 to stabilize DLX2.","date":"2022","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/35644412","citation_count":12,"is_preprint":false},{"pmid":"21397028","id":"PMC_21397028","title":"Proneural transcription factors Dlx2 and Pax6 are altered in adult SVZ neural precursor cells following striatal cell loss.","date":"2011","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/21397028","citation_count":12,"is_preprint":false},{"pmid":"33924205","id":"PMC_33924205","title":"Repeated Irradiation with γ-Ray Induces Cancer Stemness through TGF-β-DLX2 Signaling in the A549 Human Lung Cancer Cell Line.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33924205","citation_count":11,"is_preprint":false},{"pmid":"26136955","id":"PMC_26136955","title":"Effects of DLX2 overexpression on the osteogenic differentiation of MC3T3-E1 cells.","date":"2015","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26136955","citation_count":10,"is_preprint":false},{"pmid":"32862383","id":"PMC_32862383","title":"Cancer-testis Antigen OY-TES-1 Expression and Immunogenicity in Hepatocellular Carcinoma.","date":"2020","source":"Current medical science","url":"https://pubmed.ncbi.nlm.nih.gov/32862383","citation_count":9,"is_preprint":false},{"pmid":"28447749","id":"PMC_28447749","title":"Dental and periodontal phenotypes of Dlx2 overexpression in mice.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28447749","citation_count":7,"is_preprint":false},{"pmid":"39034481","id":"PMC_39034481","title":"Efficient Dlx2-mediated astrocyte-to-neuron conversion and inhibition of neuroinflammation by NeuroD1.","date":"2024","source":"Developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/39034481","citation_count":6,"is_preprint":false},{"pmid":"37365654","id":"PMC_37365654","title":"GABAergic neurons differentiated from BDNF- and Dlx2-modified neural stem cells restore disrupted neural circuits in brainstem stroke.","date":"2023","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37365654","citation_count":6,"is_preprint":false},{"pmid":"35514355","id":"PMC_35514355","title":"A Neural Crest-specific Overexpression Mouse Model Reveals the Transcriptional Regulatory Effects of Dlx2 During Maxillary Process Development.","date":"2022","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/35514355","citation_count":6,"is_preprint":false},{"pmid":"38946534","id":"PMC_38946534","title":"Osteocyte-derived exosomes regulate the DLX2/wnt pathway to alleviate osteoarthritis by mediating cartilage repair.","date":"2024","source":"Autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/38946534","citation_count":5,"is_preprint":false},{"pmid":"36384139","id":"PMC_36384139","title":"TES-1/Tes and ZYX-1/Zyxin protect junctional actin networks under tension during epidermal morphogenesis in the C. elegans embryo.","date":"2022","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/36384139","citation_count":5,"is_preprint":false},{"pmid":"39104117","id":"PMC_39104117","title":"Characteristic changes in astrocyte properties during astrocyte-to-neuron conversion induced by NeuroD1/Ascl1/Dlx2.","date":"2024","source":"Neural regeneration research","url":"https://pubmed.ncbi.nlm.nih.gov/39104117","citation_count":4,"is_preprint":false},{"pmid":"37286519","id":"PMC_37286519","title":"JMJD3 is Involved in Intracranial Aneurysm Development by Regulating DLX2 Expression through H3K27me3 Modification.","date":"2023","source":"The Tohoku journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37286519","citation_count":2,"is_preprint":false},{"pmid":"27315306","id":"PMC_27315306","title":"Overexpression of Dlx2 leads to postnatal condyle degradation.","date":"2016","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/27315306","citation_count":2,"is_preprint":false},{"pmid":"10470137","id":"PMC_10470137","title":"Establishment and characterization of human immature teratoma cell line (TES-1).","date":"1999","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10470137","citation_count":2,"is_preprint":false},{"pmid":"35463688","id":"PMC_35463688","title":"Immunohistochemistry Study of OY-TES-1 Location in Fetal and Adult Human Tissues.","date":"2022","source":"Journal of healthcare engineering","url":"https://pubmed.ncbi.nlm.nih.gov/35463688","citation_count":1,"is_preprint":false},{"pmid":"36891149","id":"PMC_36891149","title":"Effects of Dlx2 overexpression on the genes associated with the maxillary process in the early mouse embryo.","date":"2023","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36891149","citation_count":1,"is_preprint":false},{"pmid":"41533791","id":"PMC_41533791","title":"DLX2 acts as a pioneer factor and drives Msx1+ ectomesenchyme formation from embryonic stem cells.","date":"2026","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/41533791","citation_count":0,"is_preprint":false},{"pmid":"41244921","id":"PMC_41244921","title":"DLX2 promotes gastric cancer epithelial- mesenchymal transition and malignant progression through the PI3K/AKT signaling pathway.","date":"2025","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41244921","citation_count":0,"is_preprint":false},{"pmid":"41761000","id":"PMC_41761000","title":"DLX2 marks an immunosuppressive dendritic-cell program that reshapes cytotoxic immunity and marks a tolerogenic microenvironment in lung adenocarcinoma.","date":"2026","source":"Discover oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41761000","citation_count":0,"is_preprint":false},{"pmid":"41428155","id":"PMC_41428155","title":"OY-TES-1 Splice Variant V5a in Glioma: A Driver of Malignancy and Potential Therapeutic Target.","date":"2025","source":"Current medical science","url":"https://pubmed.ncbi.nlm.nih.gov/41428155","citation_count":0,"is_preprint":false},{"pmid":"14703475","id":"PMC_14703475","title":"[Expression of homeobox gene Msx-1, Msx-2 and Dlx-2 during murine mandibular first molar development].","date":"2003","source":"Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology","url":"https://pubmed.ncbi.nlm.nih.gov/14703475","citation_count":0,"is_preprint":false},{"pmid":"21779750","id":"PMC_21779750","title":"Dlx2 over-expression: a possible mechanism for first branchial arch malformation.","date":"2011","source":"Shanghai kou qiang yi xue = Shanghai journal of stomatology","url":"https://pubmed.ncbi.nlm.nih.gov/21779750","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.09.28.679022","title":"The DLX/Notch axis is necessary for spatiotemporal regulation of neural cell fate","date":"2025-09-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.28.679022","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.06.30.662293","title":"One-step induction of human GABAergic neurons promotes presynaptic development & synapse maturation","date":"2025-07-04","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.30.662293","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.18.643955","title":"Wnt signaling restores evolutionary loss of regenerative potential in <i>Hydra</i>","date":"2025-03-18","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.18.643955","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.12.03.626438","title":"Expanding GABAergic Neuronal Diversity in iPSC-Derived Disease Models","date":"2024-12-04","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.03.626438","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48270,"output_tokens":8651,"usd":0.137288},"stage2":{"model":"claude-opus-4-6","input_tokens":12489,"output_tokens":4654,"usd":0.268193},"total_usd":0.405481,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"The noncoding RNA Evf-2 (transcribed from the Dlx-5/6 ultraconserved region) forms a stable in vivo complex with DLX2 protein and acts as a transcriptional coactivator, specifically increasing DLX2-mediated transcriptional activity at the Dlx-5/6 enhancer in a target- and homeodomain-specific manner.\",\n      \"method\": \"Co-immunoprecipitation of Evf-2 ncRNA and DLX2 protein in vivo; luciferase enhancer reporter assays; neural explant treatment with Sonic hedgehog\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP (RNA-protein complex) plus functional reporter assays, moderate evidence from single lab with multiple orthogonal methods\",\n      \"pmids\": [\"16705037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Mice lacking both Dlx-1 and Dlx-2 show a time-dependent block in striatal differentiation: early-born neurons migrate to form a striosome-enriched region, but later-born neurons accumulate in the proliferative zone, establishing that Dlx-1/2 are required for development of the striatal subventricular zone and differentiation of late-born striatal matrix neurons.\",\n      \"method\": \"Targeted null mutations of Dlx-1 and Dlx-2 in mice; histological and marker analysis of striatal development\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean double-KO with defined cellular phenotype, highly cited foundational paper\",\n      \"pmids\": [\"9247261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Dlx-2 null mutation in mice causes abnormal forebrain differentiation and respecification of cranial neural crest cell fate, resulting in abnormal morphogenesis of proximal first and second branchial arch skeletal derivatives, demonstrating Dlx-2 controls both branchial arch and forebrain development.\",\n      \"method\": \"Gene targeting to generate Dlx-2 null mice; skeletal and histological analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined craniofacial and forebrain phenotype, highly cited foundational paper\",\n      \"pmids\": [\"7590232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Dlx-1 and Dlx-2 are required for proximodistal patterning of the branchial arches; Dlx-1/2 double mutants uniquely lack maxillary molars, demonstrating overlapping and distinct roles in craniofacial skeletal patterning.\",\n      \"method\": \"Targeted null mutations of Dlx-1, Dlx-2, and Dlx-1/2 double knockout mice; skeletal and soft tissue analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO/double-KO with defined skeletal phenotypes, highly cited\",\n      \"pmids\": [\"9187081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Dlx-1 and Dlx-2 specify maxillary molar ectomesenchyme as odontogenic; loss of both genes causes the molar ectomesenchyme to lose odontogenic potential and switch fate to chondrogenic, as shown by heterologous recombination between mutant and wild-type epithelium/mesenchyme and marker analysis.\",\n      \"method\": \"Dlx-1/2 double-KO mice; heterologous tissue recombination; molecular marker analysis (Barx1, Sox9)\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with epistasis via tissue recombination and molecular markers\",\n      \"pmids\": [\"9428417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Dlx1 and Dlx2 repress oligodendrocyte precursor cell (OPC) formation in the ventral telencephalon by acting on a common progenitor to determine neuronal versus oligodendroglial cell fate; Dlx1/2 negatively regulate Olig2-dependent OPC formation, and progenitors from Dlx1/2 mutant telencephalon differentiate into myelinating oligodendrocytes rather than neurons when transplanted.\",\n      \"method\": \"Dlx1/2 conditional KO mice; progenitor transplantation into wild-type mice; fate mapping\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO plus transplantation rescue experiment, strong evidence\",\n      \"pmids\": [\"17678855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Dlx2 directly activates Arx transcription through a GABAergic enhancer element containing Dlx-binding sites; Dlx overexpression induces ectopic Arx expression and its isolated enhancer, while loss of Dlx reduces Arx expression. Arx mediates Dlx-dependent promotion of interneuron migration but not GABAergic cell fate commitment.\",\n      \"method\": \"Enhancer isolation and functional characterization; Dlx gain-of-function in Arx mutant tissue; loss-of-function in Dlx mutant tissue; genetic epistasis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct enhancer functional assay with gain- and loss-of-function genetics in multiple mutant backgrounds\",\n      \"pmids\": [\"18923043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Dlx2 is necessary and sufficient for neurogenesis of virtually all OB interneurons from the lateral subependymal zone in adults, and promotes specification of periglomerular neurons toward a dopaminergic fate; this PGN subtype specification requires interaction with Pax6, as Pax6 deletion blocks Dlx2-mediated PGN specification.\",\n      \"method\": \"Retroviral vectors for cell-autonomous Dlx2 gain- and loss-of-function in adult brain; Pax6 conditional deletion; immunofluorescence\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-autonomous retroviral loss/gain-of-function with genetic epistasis (Pax6 deletion)\",\n      \"pmids\": [\"18562615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PITX2 directly binds bicoid-like elements in the Dlx2 promoter and activates Dlx2 transcription ~45-fold; Msx2 competes with PITX2 for binding to the same bicoid element and represses Dlx2 promoter activity; coexpression of PITX2 and Msx2 results in transcriptional antagonism at the Dlx2 promoter.\",\n      \"method\": \"Luciferase reporter assays; EMSA; co-expression in CHO and LS-8 tooth epithelial cell lines\",\n      \"journal\": \"Gene expression\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro reporter + EMSA, single lab\",\n      \"pmids\": [\"11763998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"BMP-2 signaling to the Col2alpha1 chondrocyte-specific enhancer requires Dlx-2; rBMP-2 upregulates Dlx-2 expression in chondroblasts at an early differentiation stage, and blocking Dlx-2 with antisense oligonucleotides or dominant-negative Smad1 abolishes BMP-2-stimulated Col2alpha1 enhancer activity, placing Dlx-2 downstream of BMP-2/Smad signaling in chondroblasts.\",\n      \"method\": \"Antisense oligonucleotides against Dlx-2; dominant-negative Smad1 expression; luciferase Col2alpha1 enhancer reporter; rBMP-2 treatment of TMC23 chondroblasts\",\n      \"journal\": \"DNA and cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional reporter with loss-of-function and epistasis, single lab\",\n      \"pmids\": [\"11445007\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DLX2 activates the Msx2 promoter and binds its DNA as a monomer and dimer; Lef-1 physically interacts with DLX2 (confirmed by Co-IP and pull-down), and co-expression of DLX2 with Lef-1 isoforms synergistically activates the Msx2 promoter; Msx2 can auto-regulate its own promoter and repress DLX2 activation in a dose-specific manner; ChIP confirmed Msx2 as a downstream target of DLX2 and Lef-1.\",\n      \"method\": \"ChIP assay; Co-immunoprecipitation; protein pull-down; luciferase reporter assays; deletion analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP + reciprocal Co-IP + pull-down + reporter assays, multiple orthogonal methods in one study\",\n      \"pmids\": [\"17068080\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DLX2 acts as a direct transcriptional repressor of TGFβ receptor II (TGFβRII) gene expression, reducing canonical Smad-dependent TGFβ signaling and p21CIP1 expression while increasing c-Myc; DLX2 also directly induces betacellulin expression to promote cell survival via EGF receptor signaling, thereby counteracting TGFβ-induced cell-cycle arrest and apoptosis.\",\n      \"method\": \"Dlx2 overexpression and knockdown in mammary epithelial cells; Western blot for pathway components; reporter assays; in vivo tumor and metastasis assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple molecular mechanisms characterized by functional assays, in vitro and in vivo, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"21897365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"DLX2 expression reduces the TTI1/TTI2/TEL2 complex (required for ATM stabilization), leading to reduced ATM-p53 signaling and senescence bypass; DLX2 overexpression extends replicative lifespan through this mechanism.\",\n      \"method\": \"Gain-of-function senescence bypass screen; Western blot for TTI1/TTI2/TEL2 complex components; ATM-p53 pathway analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional screen with mechanistic follow-up, single lab\",\n      \"pmids\": [\"26833729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Dlx-2 is induced by TGF-β and Wnt signaling and mediates TGF-β/Wnt-induced EMT and glycolytic switch through transcriptional activation of Snail; Dlx-2/Snail signaling also suppresses cytochrome c oxidase (COX) subunits including COXVIc, linking Dlx-2 to mitochondrial repression.\",\n      \"method\": \"shRNA knockdown; overexpression; RT-PCR; Western blot in cancer cell lines\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — KD/OE with phenotype and pathway placement but no direct binding shown, single lab\",\n      \"pmids\": [\"25651912\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Dlx-2 induces glutaminase (GLS1) expression in a TGF-β/Wnt-dependent manner; GLS1-mediated glutamine metabolism is required for Dlx-2-, TGF-β-, and Wnt-induced EMT and glycolytic switch; Dlx-2 and GLS1 maintain Snail mRNA levels by suppressing p53-dependent Snail-targeting microRNAs.\",\n      \"method\": \"shRNA knockdown of GLS1 and Dlx-2; glutamine deprivation; pharmacological inhibitors; in vivo metastasis assays\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — KD with multiple phenotypic readouts, pathway placement via inhibitors, single lab\",\n      \"pmids\": [\"26771232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DLX2 directly binds Dlx2-response cis-acting elements in the Osteocalcin (OCN) and Alp promoters to transactivate their expression, enhancing osteogenic differentiation and bone formation without affecting Runx2, Dlx5, Msx2, or Osterix levels.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP); site-directed mutagenesis; luciferase reporter assays; DLX2 overexpression in BMSCs and MC3T3-E1 cells; in vivo implantation in nude mice\",\n      \"journal\": \"International journal of oral science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP + mutagenesis + reporter assays + in vivo validation, multiple orthogonal methods\",\n      \"pmids\": [\"30880332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DLX2 directly drives Gad1, Gad2, and Vgat expression in cortical interneurons (CINs), as conditional Dlx1/2 knockouts show reduced mIPSC amplitude, fewer GABAergic synapses on excitatory neurons, and hypoplastic dendrites; Dlx1/2 also regulate GRIN2B expression.\",\n      \"method\": \"Conditional KO of Dlx1, Dlx2, Dlx1&2; electrophysiology (mIPSC recordings); ChIP-seq/reporter assays for direct transcriptional targets; immunostaining\",\n      \"journal\": \"Cerebral cortex\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with direct electrophysiological and molecular phenotyping, multiple orthogonal methods\",\n      \"pmids\": [\"29028947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Dlx1 and Dlx2 are required for terminal differentiation and survival of late-born retinal ganglion cells (RGCs); Dlx1/2 null retinas show reduced GCL with increased RGC apoptosis, thinning of the optic nerve, and ectopic Crx expression in GCL, while early-born RGCs and amacrine/horizontal cells are largely unaffected.\",\n      \"method\": \"Dlx1/2 double-KO mice; histological and TUNEL analysis; marker analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean double-KO with defined retinal phenotype and cell-type specificity\",\n      \"pmids\": [\"15604100\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"DLX2 directly binds a specific region of the TrkB promoter in retinal neuroepithelium during embryogenesis; ectopic Dlx2 expression in retinal explants activates TrkB expression, and Dlx2 knockdown in primary retinal cultures reduces TrkB expression, establishing TrkB as a direct Dlx2 transcriptional target required for RGC survival.\",\n      \"method\": \"ChIP assay; luciferase reporter assays; in vitro gain/loss-of-function in retinal explants and primary cultures\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP plus functional reporter + gain/loss-of-function, multiple orthogonal methods\",\n      \"pmids\": [\"18086710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"DLX1 and DLX2 function as direct transcriptional activators of Brn3b expression in the developing retina; Dlx2 knockdown in primary embryonic retinal cultures reduces Brn3b expression, and Dlx2 gain-of-function in utero increases Brn3b expression; Dlx1/2/Brn3b triple-KO shows near-total RGC loss with increased amacrine cells.\",\n      \"method\": \"Triple-KO mice (Dlx1/Dlx2/Brn3b); in utero electroporation for gain-of-function; primary retinal culture knockdown; ChIP/reporter assays\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis via triple-KO plus gain/loss-of-function in vivo and in vitro\",\n      \"pmids\": [\"28356311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The Rb/E2F pathway directly controls Dlx1 and Dlx2 expression: repressor E2Fs bind Dlx forebrain-specific enhancer I12b and Dlx1/Dlx2 proximal promoter regions, and Rb deficiency results in dramatic reduction of Dlx1 and Dlx2 expression, loss of interneuron subtypes, and severe migration defects.\",\n      \"method\": \"ChIP assay in vitro and in vivo; Rb-deficient mouse brain analysis; E2F reporter assays; interneuron subtype marker analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP in vitro and in vivo plus genetic KO with defined neurological phenotype\",\n      \"pmids\": [\"22699903\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Dlx2 overexpression in neural tube (via in ovo electroporation) inhibits neural crest cell migration and induces N-cadherin and NCAM upregulation in branchial arch mesenchyme, causing increased cell-cell adhesion and mesenchymal condensation, suggesting Dlx2 regulates ectomesenchymal cell adhesion.\",\n      \"method\": \"In ovo electroporation of chick embryos; immunostaining for N-cadherin and NCAM; cell aggregation assays\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct gain-of-function in vivo with molecular readout, single lab\",\n      \"pmids\": [\"15848386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Dlx2-expressing subpallial cells migrate ventrodorsally from the ganglionic eminences and give rise to astrocytes and oligodendrocytes in the white matter and cerebral cortex, as demonstrated by short-term lineage tracing using a Dlx2/tauLacZ knock-in.\",\n      \"method\": \"Dlx2/tauLacZ knock-in lineage tracing; immunohistochemistry for glial markers (Zebrin II); histological analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct lineage tracing experiment with functional consequence (gliogenesis)\",\n      \"pmids\": [\"12427838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DLX2 promotes the lineage transition from neural stem cells (NSCs) to transit-amplifying precursors (TAPs) in the postnatal SVZ, and also enhances the proliferative response of neuronal progenitors to EGF, demonstrating that DLX2 and EGFR signaling interact at multiple levels to coordinate SVZ progenitor proliferation.\",\n      \"method\": \"Forced DLX2 expression in SVZ-isolated NSCs; in vitro EGF response assays; in vivo modulation of DLX2\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — gain-of-function in isolated NSCs with defined proliferative phenotype, single lab\",\n      \"pmids\": [\"19683576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"I12b and URE2, two ultra-conserved DNA elements near the Dlx1/2 locus, are direct transcriptional targets of DLX2 in vivo; their proper activity requires Dlx1 and Dlx2 expression, as shown by Cre-mediated fate mapping and transgenic reporter analysis.\",\n      \"method\": \"Transgenic Cre-reporter mice; fate mapping; analysis in Dlx1/2 mutant background\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transgenic reporter plus loss-of-function genetic validation, single lab\",\n      \"pmids\": [\"19026749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Misexpression of Dlx2 alone in postnatal mouse OPCs is sufficient to switch their fate to GABAergic neurons within 2 days by downregulating Olig2 and upregulating a network of inhibitory neuron transcripts; after two weeks, some OPC-derived neurons generate trains of action potentials and form clusters of GABAergic synaptic proteins.\",\n      \"method\": \"Dlx2 misexpression in postnatal OPCs; immunostaining; electrophysiology; transcriptomic analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct gain-of-function with electrophysiological validation and molecular characterization\",\n      \"pmids\": [\"33574458\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Epithelial expression of Dlx2 in the first branchial arch is regulated by BMP4 (planar signaling within distal oral epithelium), while mesenchymal expression is regulated by FGF8 (from overlying epithelium); FGF8 also inhibits epithelial Dlx2 expression through a signaling pathway requiring the mesenchyme, establishing that BMP4 and FGF8 maintain distinct epithelial and mesenchymal Dlx2 expression domains.\",\n      \"method\": \"Transgenic lacZ reporter constructs; bead implantation for BMP4/FGF8 signaling; in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — transgenic reporters plus direct growth factor manipulation in tissue, multiple approaches\",\n      \"pmids\": [\"10603340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Radiation-induced DLX2 expression is dependent on Smad2/3 signaling; knockdown of Smad2/3 abrogates radiation-induced DLX2 upregulation, and DLX2 in turn promotes radioresistance and EMT in cancer cell lines.\",\n      \"method\": \"siRNA knockdown of Smad2/3 and DLX2; Western blot; colony formation assay; EMT marker analysis in irradiated A549 and MDA-MB-231 cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — epistasis via siRNA knockdown, single lab, single method type\",\n      \"pmids\": [\"26799321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BMP signaling through the type I receptor ALK-2 (ACVR1) induces DLX2 expression in glioma-initiating cells; DLX2 promotes apoptosis and neural differentiation of GICs, and valproic acid induces BMP2/4, ACVR1 and DLX2 expression with concomitant Smad1/5 phosphorylation.\",\n      \"method\": \"Silencing of ALK-2 and DLX2 by siRNA; mouse orthotopic transplantation model; Western blot for Smad1/5 phosphorylation; VPA treatment\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — siRNA knockdown with in vivo validation, single lab\",\n      \"pmids\": [\"28459464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DLX2 directly binds to the WNT1 promoter (confirmed by ChIP assay) and activates Wnt/β-catenin signaling, which in turn promotes osteogenic differentiation of hBMSCs; pharmacological inhibition of β-catenin (FH535) abolishes the enhanced osteogenic capability induced by DLX2.\",\n      \"method\": \"ChIP assay; luciferase reporter; Western blot; ALP assay; Alizarin red staining; FH535 inhibitor\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus epistasis via inhibitor, single lab\",\n      \"pmids\": [\"32165291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DLX2 overexpression in chondrocytes inhibits MMP13 expression by directly binding to two Dlx2-response elements in the MMP13 promoter, resulting in increased accumulation of type II collagen and aggrecan (markers of early chondrocyte differentiation).\",\n      \"method\": \"Luciferase reporter assay; ChIP assay; overexpression in TMC23 chondroblasts; RT-PCR; Western blot\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP + luciferase reporter with promoter element characterization, single lab with multiple methods\",\n      \"pmids\": [\"29787757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Mutant Runx2 induces miR-185-5p expression, which directly targets and suppresses DLX2 (confirmed by dual-luciferase reporter assay with DLX2 3'-UTR); DLX2 suppression by miR-185-5p impairs amelogenesis and osteogenesis.\",\n      \"method\": \"miRNA microarray; dual-luciferase reporter assay; RT-PCR; Western blot; mutagenesis in LS8 and MC3T3-E1 cells\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — luciferase reporter with mutagenesis confirming direct miRNA-DLX2 interaction, single lab\",\n      \"pmids\": [\"29242628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"JMJD3 demethylase promotes DLX2 expression by removing H3K27me3 repressive marks at the DLX2 locus; JMJD3 depletion phenocopies DLX2 loss in vascular smooth muscle cells (reduced proliferation, promoted apoptosis, altered collagen/MMP expression), and DLX2 overexpression in JMJD3-depleted cells restores intracranial aneurysm progression.\",\n      \"method\": \"JMJD3 knockdown; DLX2 overexpression/knockdown in HA-VSMCs; H3K27me3 ChIP; in vivo aneurysm model\",\n      \"journal\": \"The Tohoku journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP for H3K27me3 modification plus epistasis rescue experiment, single lab\",\n      \"pmids\": [\"37286519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Antisense oligonucleotide-mediated knockdown of Dlx-2 (but not Dlx-1) in primary cultures of embryonic basal ganglia decreases MAP2 expression, reduces dendrite outgrowth, and increases cell proliferation, demonstrating that the Dlx-2 gene product regulates neuronal exit from the mitotic cycle and the capability to grow MAP2-positive dendrites.\",\n      \"method\": \"Antisense oligonucleotides against Dlx-2 in primary basal ganglia cultures; MAP2 and neurofilament immunostaining; BrdU proliferation assay\",\n      \"journal\": \"Journal of molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — antisense knockdown with specific cellular phenotype, single lab\",\n      \"pmids\": [\"9188040\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"DLX2 functions as a pioneer transcription factor, forming a complex with LAP2α through a 38-amino-acid homeodomain motif, interacting with nucleosomes to promote chromatin remodeling and activate a pro-craniofacial ectomesenchymal gene network; disrupting DLX2-LAP2α interaction or silencing Dlx2 targets markedly diminishes ectomesenchymal differentiation from ESCs.\",\n      \"method\": \"Co-immunoprecipitation of DLX2-LAP2α complex; domain mutagenesis (38-aa homeodomain motif deletion); chromatin remodeling assays; ESC differentiation; CUT&Tag\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution of DLX2-LAP2α complex with mutagenesis and chromatin functional validation\",\n      \"pmids\": [\"41533791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DLX2 controls neural cell fate determination in the ventral telencephalon by directly repressing Notch signaling genes and glial fate-promoting transcription factors, thereby inhibiting early oligodendroglial differentiation during neurogenesis; single-cell spatial transcriptomics identified a secondary proliferative zone in the ventral SVZ regulated by DLX2-Notch axis.\",\n      \"method\": \"Single-cell whole-genome spatial transcriptomics; multi-omic approach; DLX2 gain/loss-of-function; Notch pathway gene expression analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multi-omic single-cell approach with direct pathway analysis, preprint not yet peer-reviewed\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"DLX2 is a homeodomain transcription factor that acts as a pioneer factor (forming a complex with LAP2α to remodel chromatin), directly activates or represses target gene promoters/enhancers (including Arx, TrkB, Brn3b, Gad1/2, Vgat, Osteocalcin, Alp, Wnt1, MMP13, and TGFβRII), cooperates with the lncRNA Evf-2 as a transcriptional coactivator, is regulated upstream by BMP/FGF/Smad/Rb-E2F pathways and H3K27me3 demethylation, and controls cell fate decisions between GABAergic neurons and oligodendrocytes in the forebrain, cranial neural crest-derived skeletal patterning in branchial arches, and osteogenic/chondrogenic differentiation, while in cancer contexts it bypasses senescence by destabilizing the ATM-stabilizing TTI1/TTI2/TEL2 complex and promotes EMT through Snail and glutamine metabolism.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DLX2 is a homeodomain transcription factor that functions as a master regulator of cell fate decisions in the developing forebrain, retina, branchial arch ectomesenchyme, and skeletal lineages. It acts as a pioneer factor by forming a complex with LAP2α through a 38-amino-acid homeodomain motif to remodel chromatin and activate pro-ectomesenchymal gene networks [PMID:41533791], and it directly binds and transactivates targets including Arx, TrkB, Brn3b, Gad1/2, Vgat, Osteocalcin, Alp, WNT1, and Msx2 while repressing TGFβRII and MMP13 [PMID:18923043, PMID:18086710, PMID:28356311, PMID:29028947, PMID:30880332, PMID:21897365, PMID:29787757]. In the forebrain, DLX2 is essential for GABAergic interneuron differentiation, migration, and synaptic function, and it determines the neuron-versus-oligodendrocyte fate choice by repressing Olig2-dependent oligodendrocyte precursor formation [PMID:9247261, PMID:17678855, PMID:33574458]. In cancer contexts, DLX2 bypasses cellular senescence by destabilizing the TTI1/TTI2/TEL2 complex to suppress ATM-p53 signaling and promotes epithelial-mesenchymal transition through Snail induction and glutamine metabolism reprogramming [PMID:26833729, PMID:25651912, PMID:26771232].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing that DLX2 is required for both forebrain differentiation and branchial arch skeletal patterning answered the foundational question of where and when this transcription factor acts during embryogenesis.\",\n      \"evidence\": \"Dlx-2 null mice showing abnormal forebrain and respecified cranial neural crest fate\",\n      \"pmids\": [\"7590232\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream transcriptional targets unknown\", \"Mechanism of cell fate respecification undefined\", \"Redundancy with Dlx-1 not yet dissected\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Systematic analysis of Dlx-1, Dlx-2, and double-knockout mice revealed that DLX1/2 have overlapping roles in striatal neurogenesis, branchial arch patterning, odontogenic specification, and cell cycle exit, clarifying the cooperative logic of the Dlx gene family.\",\n      \"evidence\": \"Dlx-1/2 single and double-KO mice with skeletal, striatal, and dental phenotypes; tissue recombination experiments; antisense knockdown in basal ganglia cultures\",\n      \"pmids\": [\"9247261\", \"9187081\", \"9428417\", \"9188040\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets of DLX2 not identified\", \"Whether DLX2 acts as activator or repressor unknown\", \"Signaling pathways upstream of DLX2 in these contexts undefined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of BMP4 and FGF8 as upstream regulators maintaining distinct epithelial and mesenchymal DLX2 expression domains in the branchial arch placed DLX2 downstream of key morphogenetic signaling pathways.\",\n      \"evidence\": \"Transgenic lacZ reporters with BMP4/FGF8 bead implantation in mouse mandibular arch\",\n      \"pmids\": [\"10603340\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether BMP/FGF regulate DLX2 directly or indirectly unresolved\", \"Cis-regulatory elements mediating this regulation not mapped\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Placing DLX2 downstream of BMP-2/Smad signaling in chondroblasts and demonstrating PITX2/Msx2 competition at the DLX2 promoter defined the transcriptional regulatory logic controlling DLX2 expression in skeletal and dental contexts.\",\n      \"evidence\": \"Antisense and dominant-negative Smad1 blocking BMP-2-induced Col2α1 enhancer activity; EMSA and luciferase reporters for PITX2/Msx2 binding to DLX2 promoter\",\n      \"pmids\": [\"11445007\", \"11763998\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo validation of PITX2-DLX2 regulatory axis lacking\", \"Whether DLX2 directly binds Col2α1 enhancer not shown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrating that Dlx1/2 are required for late-born retinal ganglion cell survival extended the known developmental roles of DLX2 beyond forebrain and craniofacial tissues to the retina.\",\n      \"evidence\": \"Dlx1/2 double-KO retinal analysis showing RGC apoptosis and optic nerve thinning\",\n      \"pmids\": [\"15604100\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets of DLX2 in retina unknown\", \"Whether DLX2 acts cell-autonomously in RGCs not established\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Discovery that the lncRNA Evf-2 forms a complex with DLX2 to coactivate the Dlx-5/6 enhancer, and that DLX2 synergizes with Lef-1 to activate Msx2, revealed two distinct modes of DLX2 transcriptional co-regulation — one RNA-dependent and one protein-protein dependent.\",\n      \"evidence\": \"Co-IP of Evf-2/DLX2 complex and enhancer reporter assays; ChIP and reciprocal Co-IP of DLX2-Lef-1 with Msx2 promoter activation\",\n      \"pmids\": [\"16705037\", \"17068080\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Evf-2/DLX2 interaction unknown\", \"Whether Evf-2 coactivation applies to targets beyond Dlx-5/6 enhancer untested\", \"Genome-wide DLX2-Lef-1 co-occupancy not mapped\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Establishing that DLX1/2 control the neuron-versus-oligodendrocyte fate decision by repressing Olig2-dependent OPC formation, and identifying TrkB as a direct DLX2 transcriptional target in retina, revealed DLX2 as a binary fate switch and defined its first direct target genes.\",\n      \"evidence\": \"Dlx1/2 conditional KO with OPC transplantation into wild-type brain; ChIP and gain/loss-of-function for DLX2 at TrkB promoter in retina\",\n      \"pmids\": [\"17678855\", \"18086710\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether DLX2 directly binds Olig2 regulatory elements unknown\", \"Mechanism by which DLX2 represses oligodendroglial fate not molecularly defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of Arx as a direct DLX2 target mediating interneuron migration, and demonstration that DLX2 is necessary and sufficient for olfactory bulb interneuron neurogenesis with Pax6-dependent dopaminergic subtype specification, mapped the downstream transcriptional cascade controlling GABAergic interneuron diversification.\",\n      \"evidence\": \"Enhancer isolation and genetic epistasis for Arx; retroviral gain/loss-of-function for DLX2 in adult SVZ with Pax6 conditional deletion\",\n      \"pmids\": [\"18923043\", \"18562615\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether DLX2 directly interacts with Pax6 protein unknown\", \"Full set of DLX2-regulated enhancers in interneurons not cataloged\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrating that DLX2 directly represses TGFβRII to block TGFβ-induced growth arrest and apoptosis while inducing betacellulin/EGFR signaling revealed a pro-oncogenic mechanism through which a developmental transcription factor subverts growth control.\",\n      \"evidence\": \"DLX2 overexpression/knockdown in mammary epithelial cells with in vivo tumor and metastasis assays\",\n      \"pmids\": [\"21897365\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TGFβRII repression involves direct DLX2 binding to promoter (ChIP) not shown in this study\", \"Relevance to human cancer in vivo not validated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Establishing that the Rb/E2F pathway directly controls DLX2 expression by binding the I12b forebrain enhancer and proximal promoter linked DLX2 to cell cycle regulation and explained how Rb deficiency leads to interneuron loss.\",\n      \"evidence\": \"ChIP for E2F binding in vitro and in vivo; Rb-deficient mouse brain with interneuron phenotyping\",\n      \"pmids\": [\"22699903\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which specific E2F family members are activating versus repressing DLX2 unclear\", \"Whether E2F-DLX2 axis operates outside the forebrain unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Linking DLX2 to TGFβ/Wnt-induced EMT via Snail activation and metabolic reprogramming (glycolytic switch, GLS1-dependent glutamine metabolism) expanded the oncogenic function of DLX2 beyond growth control to include metabolic and migratory programs.\",\n      \"evidence\": \"shRNA knockdown and overexpression in cancer cell lines; GLS1 epistasis with in vivo metastasis assays\",\n      \"pmids\": [\"25651912\", \"26771232\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding of DLX2 to Snail or GLS1 promoters not demonstrated by ChIP\", \"Whether metabolic reprogramming is relevant to normal DLX2 developmental functions unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Discovery that DLX2 bypasses senescence by destabilizing the TTI1/TTI2/TEL2 complex to suppress ATM-p53 signaling provided a specific molecular mechanism for DLX2's oncogenic role distinct from its TGFβRII repression.\",\n      \"evidence\": \"Gain-of-function senescence bypass screen; Western blot for TTI1/TTI2/TEL2 complex\",\n      \"pmids\": [\"26833729\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether DLX2 transcriptionally represses TTI1/TTI2/TEL2 components or acts post-transcriptionally unresolved\", \"Not independently confirmed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Triple-KO genetic epistasis demonstrated that DLX1/2 directly activate Brn3b to specify retinal ganglion cells, and that miR-185-5p targets DLX2 for suppression in skeletal lineages, revealing both a downstream effector in the retina and a post-transcriptional regulatory mechanism.\",\n      \"evidence\": \"Dlx1/Dlx2/Brn3b triple-KO with near-total RGC loss; dual-luciferase reporter confirming miR-185-5p targeting of DLX2 3'-UTR\",\n      \"pmids\": [\"28356311\", \"29242628\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Brn3b is sufficient to rescue RGC loss in Dlx1/2 mutants untested\", \"Full spectrum of miRNAs regulating DLX2 not surveyed\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Conditional knockout studies in cortical interneurons established that DLX1/2 directly drive GABAergic synaptic gene expression (Gad1, Gad2, Vgat) and are required for normal inhibitory synaptic transmission, and ChIP identified DLX2 binding at the MMP13 promoter to repress chondrocyte hypertrophy, expanding the catalog of direct targets across tissues.\",\n      \"evidence\": \"Conditional Dlx1/2 KO with mIPSC recordings and ChIP-seq/reporters; ChIP and luciferase for MMP13 in chondroblasts\",\n      \"pmids\": [\"29028947\", \"29787757\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide DLX2 cistrome in interneurons not fully characterized\", \"Whether MMP13 repression is relevant in vivo during skeletal development unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"ChIP and mutagenesis demonstrated that DLX2 directly transactivates Osteocalcin and Alp promoters to enhance bone formation independently of Runx2 and Osterix, establishing a direct osteogenic transcriptional program.\",\n      \"evidence\": \"ChIP, site-directed mutagenesis, luciferase reporters in BMSCs/MC3T3-E1 cells; in vivo implantation\",\n      \"pmids\": [\"30880332\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether DLX2 cooperates with other osteogenic factors at these promoters untested\", \"Physiological requirement for DLX2 in adult bone homeostasis unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrating that DLX2 alone is sufficient to reprogram postnatal OPCs into functional GABAergic neurons within days confirmed DLX2 as a dominant determinant of the neuron-oligodendrocyte binary fate switch and opened therapeutic reprogramming possibilities.\",\n      \"evidence\": \"DLX2 misexpression in postnatal OPCs with electrophysiology and transcriptomics\",\n      \"pmids\": [\"33574458\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term stability and integration of reprogrammed neurons not established\", \"Whether DLX2-reprogrammed neurons are functionally equivalent to endogenous interneurons unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identification of DLX2 as a pioneer transcription factor that complexes with LAP2α via a 38-amino-acid homeodomain motif to remodel chromatin and activate ectomesenchymal gene networks fundamentally redefined the mechanism by which DLX2 accesses its target genes.\",\n      \"evidence\": \"Co-IP, domain mutagenesis, CUT&Tag chromatin profiling, ESC differentiation assays\",\n      \"pmids\": [\"41533791\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether LAP2α interaction is required for DLX2 pioneer activity in neural contexts untested\", \"Structural basis of DLX2-nucleosome interaction unresolved\", \"Whether all DLX2 targets require pioneer activity unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A comprehensive genome-wide DLX2 cistrome across developmental contexts, the structural basis of DLX2 pioneer activity and LAP2α interaction, and the relevance of DLX2's oncogenic mechanisms (TTI1/TTI2/TEL2, metabolic reprogramming) to normal physiology remain to be established.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No genome-wide DLX2 binding map across multiple tissues and developmental stages\", \"No crystal or cryo-EM structure of DLX2 bound to nucleosome or LAP2α\", \"Whether DLX2 pioneer activity is relevant in the forebrain or retina not tested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [6, 10, 15, 18, 29, 30, 34]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 6, 10, 11, 15, 16, 18, 19, 29, 30, 34]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 10, 15, 34]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [34]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 6, 10, 11, 15, 16, 18, 19, 29, 30, 34]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 2, 3, 4, 5, 7, 17, 19, 22, 25]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [34]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 11, 26, 28, 29]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [1, 5, 6, 7, 16, 25]}\n    ],\n    \"complexes\": [\n      \"DLX2-LAP2α chromatin remodeling complex\",\n      \"DLX2-Evf-2 lncRNA coactivator complex\"\n    ],\n    \"partners\": [\n      \"LAP2A\",\n      \"LEF1\",\n      \"PAX6\",\n      \"PITX2\",\n      \"MSX2\",\n      \"SMAD1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}